1: A novel heterocyclic ring amide compound with the following characteristics: 1 (E) - 1 - (4 - (5-carbamoil-2 - (1-ethyl-3-methyl-methyl-1-h-pirazol-5-carboxamido) - 7 - (3-morpolinopopoxi) - 7 - (3-morpolinopopoxi) - 1 h-benzo [D] imidazol-1-1-1-il] (1-il) but-2-en-1-1-il) - 2 - (1-ethyl-3-methyl-1-1h-1h-picazole-5-carboxamido-5-5-carboxamido) - 7-3 - (3-methyl-methyl-1-1-1h-1h-pizol-5-5-5-carboxamido-7 - (3-morpolinoropoxi) - 7 - (3-morpholipoxi-morpho-- toluene - O - O - O - O - toluene - O - O - O - O - toluene - O - O - O - O - benzene - formula (1) Either it's a Taurus, or it's a medically acceptable salt, or it's a hydrate.Reivindicación 1: Un compuesto de amida heterocíclico caracterizado porque es (E)-1-(4-(5-carbamoil-2-(1-etil-3-metil-1H-pirazol-5-carboxamido)-7-(3-morfolinopropoxi)-1H-benzo[d]imidazol-1-il)but-2-en-1-il)-2-(1-etil-3-metil-1H-pirazol-5-carboxamido)-7-metoxi-1H-benzo[d]imidazol-5-carboxamida con la estructura de fórmula (1), o un tautómero del mismo, o una sal farmacéuticamente aceptable del mismo, o un hidrato del mismo.
